AF
MBX

Allworth Financial’s MBX Biosciences MBX Stock Holding History

Allworth Financial’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.09K Buy
70
+18
+35% +$612 ﹤0.01% 4341
2025
Q4 		$1.64K Buy
52
+27
+108% +$655 ﹤0.01% 4206
2025
Q3 		$438 Hold
25
– – ﹤0.01% 4472
2025
Q2 		$286 Buy
+25
New +$255 ﹤0.01% 4259

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Allworth Financial's MBX Position: Q1 2026 in Review

Allworth Financial increased its MBX Biosciences (MBX) stake by 35% in Q1 2026, buying an estimated $612 and bringing the position to 70 shares worth $2.09K. The position accounts for ﹤0.01% of the portfolio, ranked #4341.

Allworth Financial first reported a position in MBX in Q2 2025 and has held it in 4 quarters since. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Allworth Financial held 70 shares of MBX Biosciences worth $2.09K as of Q1 2026.
  • Allworth Financial bought 18 MBX Biosciences shares in Q1 2026, an estimated $612.
  • MBX Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4341 holding.
  • Allworth Financial first reported a position in MBX Biosciences in Q2 2025 and has held it in 4 quarters since.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.